In vitro fertilization: Do short-term changes in estrogen levels produce increased fibrinolysis?

American Journal of Clinical Pathology

Volumn 112, Issue 4, 1999, Pages 485-491

  Magnani, Barbarajean ^a,b,c   Tsen, Lawrence ^a   Datta, Sanjay ^a   Bader, Angela ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BOSTON MEDICAL CENTER   (United States)

Author keywords

Estrogen; Fibrinolysis; In vitro fertilization; Platelets

Indexed keywords

ALPHA 2 ANTIPLASMIN; D DIMER; ESTROGEN; FIBRINOGEN; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN ANTITHROMBIN COMPLEX;

ARTICLE; CLINICAL ARTICLE; ESTROGEN BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; FIBRINOLYSIS; FLOW CYTOMETRY; HUMAN; PRIORITY JOURNAL;

EID: 0033491391     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/112.4.485     Document Type: Article

References (24)

1. Mann J, Inman WH. Oral contraceptives and death from myocardial infarction. BMJ. 1975;2:245-248.
2. Koh KK, Mincemoyer R, Bui MN, et al. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women. N Engl J Med. 1997;336:683-690.
3. Fareed J, Bick RL, Hoppensteadt DA, et al. Molecular markers of hemostatic activation: applications in the diagnosis of thrombosis and vascular and thrombotic disorders. Clin Appl Thromb Hemost. 1995;1:87-102.
4. Kessler C, Szymanski LM, Shamsipour Z, et al. Estrogen replacement therapy and coagulation: relationship to lipid and lipoprotein changes. Obstet Gynecol. 1997;89:326-331.
5. Jackson KV, Nurreddin A, Clarke RN, et al. The appearance of one pronuclear human oocyte is associated with a better ovulation induction response and successful pregnancy outcome. Fertil Steril. 1992;58:366-372.
6. Magnani B, Fenton T, Lapp C, et al. Degree of agreement in plasma fibrinogen among two functional and one immunonephelometric assays. Am J Clin Pathol. 1997;107:527-533.
7. Ault KA, Rinder HM, Mitchell JG, et al. Correlated measurement of platelet release and aggregation in whole blood. Cytometry. 1989;10:448-455.
8. Shattil SJ, Cunningham M, Hoxie JA. Detection of activated platelets in whole blood using activation-dependent monoclonal antibodies and flow cytometry. Blood. 1987;307-315.
9. Kinder CS, Matther JP, Kinder HM, et al. Platelet activation and aggregation during cardiopulmonary bypass. Anesthesiology. 1991;75:388-393.
10. Michelson A. Flow cytometry: a clinical test of platelet functions. Blood. 1996;87:4925-4936.
11. Morse D, Adams D, Magnani BJ. Platelet and neutrophil activation during cardiac surgical procedures: impact of cardiopulmonary bypass. Ann Thoracic Surg. 1998;65:691-695.
12. Buster JE, Chang RJ, Preston DL, et al. Interrelationships of circulating maternal steroid concentrations in third trimester pregnancies, II: C18 and C19 steroids: estradiol, estriol, dehydroepiandrosterone, dehydroepiandrosterone sulfate, D5-andostenediol, D4-androstenedione, testosterone, and dihydrotestosterone. J Clin Endocrinol Metab. 1979;48:139-142.
13. Montes R, Paramo JA, Angles-Cano E, et al. Development and clinical application of a new ELISA assay to determine plasmin-alpha2-antiplasmin complexes in plasma. Br J Haematol. 1996;92:979-985.
14. Porter KR, Hawn C, Von Z. The culture of tissue culture cells in clots formed from purified bovine fibrinogen and thrombin. Proc Soc Exp Biol Med. 1947;65;309-314.
15. Blomback M, Carlsson K, Fatah K, et al. Fibrin gel structure in health and disease. In: Ernst E, Koenig W, Lowe G, et al, eds. Fibrinogen: A New Cardiovascular Risk Factor. Portland, OR: Blackwell-MZV; 1992:11-18.
16. Lecander I, Astedt B. Isolation of a new specific plasminogen activator inhibitor from pregnancy plasma. Br J Haematol. 1986;62:221-228.
17. Kodama H, Matsui T, Fukuda J, et al. Status of the coagulation and fibrinolytic systems in ovarian hyperstimulation syndrome. Fertil Steril. 1996;66:417-424.
18. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemost. 1988;59:101-106.
19. Norris LA, Bonnar J. Effect of oestrogen dose on whole blood platelet activation in women taking new low dose oral contraceptives. Thromb Haemost. 1994;72:926-930.
20. Hanss M, Trzeciak MC, Ninet J, et al. Decreased plasma fibrin degradation products during hormonal stimulation for in vitro fertilization. Fibrinolysis. 1993;7:341-346.
21. Rice VC, Richard-Davis G, Saleh A, et al. Fibrinolytic parameters in women undergoing ovulation induction. Am J Obstet Gynecol. 1993;169:1549-1553.
22. Manaka C, Akabori A, Araki S, et al. Changes in coagulability and fibrinolytic activity in the patients with ovarian hyperstimulation syndrome [in Japanese]. Nippon Sanka Fujinka Gakkai Zasshi. 1991;43:1653-1659.
23. Kodama H, Fukada J, Karube H, et al. Characteristics of blood hemostatic markers in a patient with ovarian hyperstimulation syndrome who actually developed thromboembolism. Fertil Steril. 1995;64:1207-1209.
24. Aune B, Oian P, Osterud B. Enhanced sensitivity of the extrinsic coagulation system during ovarian stimulation for in vitro fertilization. Hum Reprod. 1993;9:1349-1352.